We have located links that may give you full text access.
Impaired reverse cholesterol transport is associated with changes in fatty acid profile in children and adolescents with abdominal obesity.
Journal of Nutrition 2023 September 15
BACKGROUND: Abdominal obesity is an important cardiovascular risk factor. Plasma fatty acids display a complex network of both pro and antiatherogenic effects. High density lipoproteins (HDL) carry out the antiatherogenic pathway called reverse cholesterol transport (RCT), which involves cellular cholesterol efflux (CCE), and lecithin:cholesterol acyltransferase (LCAT) and cholesteryl ester transfer protein (CETP) activities.
OBJECTIVE: Our aim was to characterize RCT and its relation to fatty acids present in plasma in pediatric abdominal obesity.
METHODS: Seventeen children and adolescents with abdominal obesity and 17 healthy controls were studied. Anthropometric parameters were registered. Glucose, insulin, lipid levels, CCE employing THP-1 cells, LCAT and CETP activities, plus fatty acids in apo B-depleted plasma were measured.
RESULTS: The obese group showed a more atherogenic lipid profile, plus lower CCE (Mean±Standard Deviation) (6±2 vs. 7±2%; p<0.05) and LCAT activity (11±3 vs. 15±5 umol/dL.h; p<0.05). With respect to fatty acids, the obese group showed higher myristic (1.1±0.3 vs. 0.7±0.3; p<0.01) and palmitic acids (21.5±2.8 vs 19.6±1.9; p<0.05) in addition to lower linoleic acid (26.4±3.3 vs. 29.9±2.6; p<0.01). Arachidonic acid correlated with CCE (r=0.37; p<0.05), myristic acid with LCAT (r=-0.37; p<0.05), palmitioleic acid with CCE (r=-0.35; p<0.05), linoleic acid with CCE (r=0.37; p<0.05), lauric acid with LCAT (r=0.49; p<0.05), myristic acid with LCAT (r=-0.37; p<0.05) ecoisatrienoic acid with CCE (r=0.40; p<0.05) and lignoseric acid with LCAT (r=-0.5; p<0.01).
CONCLUSION: Children and adolescents with abdominal obesity presented impaired RCT, which was associated with modifications in proinflammatory fatty acids, such as palmitoleic and myristic, thus contributing to increased cardiovascular risk.
OBJECTIVE: Our aim was to characterize RCT and its relation to fatty acids present in plasma in pediatric abdominal obesity.
METHODS: Seventeen children and adolescents with abdominal obesity and 17 healthy controls were studied. Anthropometric parameters were registered. Glucose, insulin, lipid levels, CCE employing THP-1 cells, LCAT and CETP activities, plus fatty acids in apo B-depleted plasma were measured.
RESULTS: The obese group showed a more atherogenic lipid profile, plus lower CCE (Mean±Standard Deviation) (6±2 vs. 7±2%; p<0.05) and LCAT activity (11±3 vs. 15±5 umol/dL.h; p<0.05). With respect to fatty acids, the obese group showed higher myristic (1.1±0.3 vs. 0.7±0.3; p<0.01) and palmitic acids (21.5±2.8 vs 19.6±1.9; p<0.05) in addition to lower linoleic acid (26.4±3.3 vs. 29.9±2.6; p<0.01). Arachidonic acid correlated with CCE (r=0.37; p<0.05), myristic acid with LCAT (r=-0.37; p<0.05), palmitioleic acid with CCE (r=-0.35; p<0.05), linoleic acid with CCE (r=0.37; p<0.05), lauric acid with LCAT (r=0.49; p<0.05), myristic acid with LCAT (r=-0.37; p<0.05) ecoisatrienoic acid with CCE (r=0.40; p<0.05) and lignoseric acid with LCAT (r=-0.5; p<0.01).
CONCLUSION: Children and adolescents with abdominal obesity presented impaired RCT, which was associated with modifications in proinflammatory fatty acids, such as palmitoleic and myristic, thus contributing to increased cardiovascular risk.
Full text links
Related Resources
Trending Papers
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.International Journal of Molecular Sciences 2024 April 13
Executive Summary: State-of-the-Art Review: Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults.Clinical Infectious Diseases 2024 April 11
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Finerenone: From the Mechanism of Action to Clinical Use in Kidney Disease.Pharmaceuticals 2024 March 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app